Mesa Laboratories, Inc. (MLAB)
129.09
+0.44
(+0.34%)
USD |
NASDAQ |
Aug 28, 16:00
126.88
-2.21
(-1.71%)
After-Hours: 20:00
Mesa Laboratories Cash from Operations (Quarterly) : 14.74M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.74M |
| March 31, 2026 | 13.96M |
| December 31, 2025 | 18.75M |
| September 30, 2025 | 8.222M |
| June 30, 2025 | 1.893M |
| March 31, 2025 | 12.66M |
| December 31, 2024 | 18.44M |
| September 30, 2024 | 5.271M |
| June 30, 2024 | 10.74M |
| March 31, 2024 | 12.88M |
| December 31, 2023 | 11.54M |
| September 30, 2023 | 9.776M |
| June 30, 2023 | 9.939M |
| March 31, 2023 | 12.52M |
| December 31, 2022 | 7.718M |
| September 30, 2022 | 10.56M |
| June 30, 2022 | -2.811M |
| March 31, 2022 | 9.302M |
| December 31, 2021 | 15.90M |
| September 30, 2021 | 4.434M |
| June 30, 2021 | 9.589M |
| March 31, 2021 | 13.52M |
| December 31, 2020 | 10.94M |
| September 30, 2020 | 10.35M |
| June 30, 2020 | 2.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.832M |
| December 31, 2019 | 11.01M |
| September 30, 2019 | 6.425M |
| June 30, 2019 | 0.724M |
| March 31, 2019 | 10.26M |
| December 31, 2018 | 10.09M |
| September 30, 2018 | 3.657M |
| June 30, 2018 | 6.543M |
| March 31, 2018 | 9.641M |
| December 31, 2017 | 7.805M |
| September 30, 2017 | 4.687M |
| June 30, 2017 | 2.681M |
| March 31, 2017 | 0.979M |
| December 31, 2016 | 5.442M |
| September 30, 2016 | -2.303M |
| June 30, 2016 | 3.632M |
| March 31, 2016 | 6.95M |
| December 31, 2015 | 0.991M |
| September 30, 2015 | 6.101M |
| June 30, 2015 | 2.861M |
| March 31, 2015 | 4.64M |
| December 31, 2014 | 2.432M |
| September 30, 2014 | 3.318M |
| June 30, 2014 | 0.426M |
| March 31, 2014 | 2.899M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 519.00M |
| Bio-Rad Laboratories, Inc. | 98.70M |
| Bruker Corp. | -77.40M |
| Danaher Corp. | 1.534B |
| Harvard Bioscience, Inc. | 0.323M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.559M |
| Cash from Financing (Quarterly) | -10.50M |
| Free Cash Flow | 52.87M |
| Free Cash Flow Per Share (Quarterly) | 2.463 |
| Free Cash Flow to Equity (Quarterly) | 21.66M |
| Free Cash Flow to Firm (Quarterly) | 15.71M |
| Free Cash Flow Yield | 7.31% |